Bruns Ingmar
Insider CIK 1838041 · TRIL Chief Medical Officer · ZNTL Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ZNTL Zentalis Pharmaceuticals, | A Award | 2026-09-30 | 2026-10-01 | 9,727 | $2.18 | $21.2K | 43,059 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2026-02-09 | 2026-02-10 | 335 | $2.39 | $801 | 33,332 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2026-02-06 | 2026-02-10 | 2,962 | $2.43 | $7.2K | 33,667 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2026-01-08 | 2026-01-09 | 365,000 | — | $0 | 365,000 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | P Buy | 2025-02-06 | 2025-02-12 | 20,000 | $2.28 | $45.6K | 36,629 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2025-02-03 | 2025-02-05 | 16,629 | — | $0 | 16,629 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award | 2025-02-03 | 2025-02-05 | 16,629 | — | $0 | 16,629 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2024-12-02 | 2024-12-03 | 712,650 | — | $0 | 712,650 | SEC↗ |
| TRIL Trillium Therapeutics Inc. | D To issuer deriv | 2021-11-17 | 2021-11-19 | 400,000 | — | $0 | 0 | SEC↗ |